News & Insights

We recently held a webinar featuring a presentation from Dr Nick Skaer, CEO of portfolio company Orthox.

We recently held a webinar featuring presentations from Christoph Birkl (CEO) & Carolyn Hicks (CFO/COO) of portfolio company Brill Power, and Barnaby Balmforth, CEO of portfolio company Biofidelity.

We recently held a webinar featuring presentations from Chris Case, CTO of portfolio company Oxford PV, and Craig Marshall, CEO of portfolio company OrganOx!

• Oxford Endovascular Ltd is commercialising OxiFlow™, a novel blood flow diversion device (‘stent’) for treating Intracranial Aneurysms (ICAs).
• OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a $10m Series A funding round led by Vulpes Investment Management, a Singapore-based life sciences investor.
• This is the second OTIF investment in Oxford Endovascular to date, bringing total funds invested by the fund in the Company to £500k.

We recently held the second webinar in our series of two events celebrating British innovation and new technologies held in conjunction with our friends at Rathbone Investment Management.